Sanders Morris Harris’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,778
Closed -$1.79M 157
2026
Q1
$1.79M Buy
+3,778
New +$1.9M 0.28% 78
2025
Q4
Sell
-3,781
Closed -$1.61M 145
2025
Q3
$1.61M Buy
+3,781
New +$1.47M 0.21% 67
2025
Q2
Sell
-3,781
Closed -$1.31M 219
2025
Q1
$1.31M Hold
3,781
0.2% 68
2024
Q4
$1.13M Hold
3,781
0.17% 86
2024
Q3
$1.54M Hold
3,781
0.25% 56
2024
Q2
$1.21M Hold
3,781
0.2% 70
2024
Q1
$1.26M Buy
3,781
+51
+1% +$15.6K 0.23% 65
2023
Q4
$1.05M Sell
3,730
-51
-1% -$12.6K 0.51% 49
2023
Q3
$928K Hold
3,781
0.19% 73
2023
Q2
$1.13M Buy
+3,781
New +$1.05M 0.25% 56
2023
Q1
Sell
-3,631
Closed -$871K 192
2022
Q4
$871K Hold
3,631
0.33% 63
2022
Q3
$703K Hold
3,631
0.17% 97
2022
Q2
$636K Hold
3,631
0.14% 110
2022
Q1
$910K Hold
3,631
0.18% 94
2021
Q4
$921K Hold
3,631
0.16% 96
2021
Q3
$881K Hold
3,631
0.16% 101
2021
Q2
$780K Hold
3,631
0.15% 119
2021
Q1
$678K Hold
3,631
0.14% 117
2020
Q4
$618K Hold
3,631
0.14% 129
2020
Q3
$481K Buy
+3,631
New +$449K 0.13% 153

Other funds holding HCA

Sanders Morris Harris's HCA Position: Q2 2026 in Review

Sanders Morris Harris sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 3,778 shares — an estimated $1.79M sold.

Sanders Morris Harris first reported a position in HCA in Q3 2020 and held it in 20 quarters. The position peaked at $1.79M in Q1 2026. 185 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Sanders Morris Harris reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
  • Sanders Morris Harris sold 3,778 HCA Healthcare shares in Q2 2026, an estimated $1.79M.
  • Sanders Morris Harris first reported a position in HCA Healthcare in Q3 2020 and held it in 20 quarters.
  • Sanders Morris Harris's HCA Healthcare position peaked at $1.79M in Q1 2026.
  • 185 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Sanders Morris Harris's 13F filing for Q2 2026, filed 7 Jul 2026.